⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

ZTS

Zoetis Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

73.31USD

-0.2500 (-0.34%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 73.31
P/E11.6
Dvd Ind Yld2.9%
P/B9.62
P/S3.2
Curr EV/T12M EBITDA9.3
Mkt Cap (USD)30.3B
Curr EV (USD)37.9B
2)

Per Share Data

EPS T12M6.06
DPS2.12
Bk Val Per Sh7.54
Rev/Sh22.78
Cash/Sh4.06
Curr Shares Out413.2M
FCF/Sh5.54
3)

Cash Flow Analysis

P/CF10.7
Curr P/FCF13.1
CF/NI1.1
Dvd P/O33.6%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales29.8%
Eff Interest Rate3.0%
4)

Growth Potential

Dil EPS 1Y Gr10.1%
Cap 1Y Gr9.9%
BPS 1Y Gr-26.6%
R&D To Sales—
Retention Rate66.4%
Rev 1Y Gr2.3%
FCF 1Y Gr-0.7%
Assets 1Y Gr8.8%
5)

Profitability

EBITDA4.1B
EBIT—
Operating Margin40.7%
Pretax Margin34.4%
Net Margin27.5%
ROA17.7%
ROE64.4%
ROC—
Asset Turnover0.64
6)

Structure

Current Ratio3.08
Quick Ratio1.58
Debt/Assets60.0%
Debt/Com Eq287.4%
Net Debt/EBITDA1.86
Tot Debt/Capital74.2%
Gross Margin71.5%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.